The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The cancer supportive care products market size has grown steadily in recent years, growing from $20.58 billion in 2023 to $21.56 billion in 2024 at a compound annual growth rate (CAGR) of 4.8%. This growth during the historic period is attributed to factors such as a rise in cancer incidence, increased awareness and education, improved healthcare infrastructure, a growing geriatric population, and early detection measures. Moving forward, the cancer supportive care products market size is projected to continue its steady growth, reaching $26.1 billion by 2028 at a CAGR of 4.9%. The growth during the forecast period will be driven by the increasing prevalence of cancer, a growing focus on personalized medicine, patient-centric approaches, investment in cancer research, and rising cancer survival rates. Key trends expected to shape the market include advancements in technology, the development of advanced drug delivery systems, new drug formulations, personalized care, and the creation of biodegradable products.

The increasing cancer incidence is expected to propel the growth of the cancer supportive care products market going forward. As populations age, the risk of developing cancer increases due to cellular changes and prolonged exposure to risk factors. Additionally, factors such as smoking, poor diet, lack of physical activity, and excessive alcohol consumption contribute significantly to cancer risk. Cancer supportive care products are used to manage symptoms, improve quality of life, and support patients undergoing treatment, addressing the growing need due to the increasing incidence of cancer. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, there were projected to be 58,450 cases of oral cavity and pharynx cancer, reflecting a 7.2% increase from the 54,540 cases reported in 2023. Therefore, the increasing cancer incidence will drive the growth of the cancer supportive care products market.

Get A Free Sample On The Cancer Supportive Care Products Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18529&type=smp

What Are The Key Trends That Influence Cancer Supportive Care Products Market Share Analysis?

Major companies in the cancer supportive care products market are emphasizing advancements in cancer therapies, including a targeted radioligand therapy (RLT) platform, to enhance treatment efficacy, minimize side effects, and improve overall patient outcomes. A targeted radioligand therapy (RLT) platform employs radiolabeled molecules that selectively bind to cancer cell markers, delivering localized radiation to effectively destroy cancer cells while preserving healthy tissue. For instance, in May 2022, Novartis AG, a Swiss pharmaceutical corporation, received approval from the U.S. Food and Drug Administration (FDA) for Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to treat adult patients with prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer (PSMA-positive mCRPC) that has progressed despite prior treatments. Pluvicto marks the first FDA-approved targeted radioligand therapy (RLT) for eligible mCRPC patients, combining a targeting ligand with a therapeutic radioisotope. The FDA also approved Locametz (gallium Ga 68 gozetotide injection), used in PET scans to detect PSMA-positive lesions, aiding in the identification of cancer spread and determining eligibility for Pluvicto treatment.

Which Market Players Are Driving Growth In The Cancer Supportive Care Products Market?

Major companies operating in the cancer supportive care products market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Becton Dickinson and Company, Teva Pharmaceutical Industries Limited, Baxter International Inc., Daiichi Sankyo Company Limited, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Kyowa Hakko Kirin Co. Ltd., QIAGEN N.V., Exelixis Inc., Fagron Group B.V., Tessa Therapeutics Pte Ltd., Mirati Therapeutics Inc., APR Applied Pharma Science Research S.A., Acacia Pharma Ltd., Arquer Diagnostics Ltd.

How Is The Global Cancer Supportive Care Products Market Segmented?

The cancer supportive care productsmarket covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs, Anti-Infective, Anti-Emetics, Monoclonal Antibodies, Erythropoietin Stimulating Agents, Opioid Analgesics, Bisphosphonates, Granulocyte Colony Stimulating Factor
2) By Indication: Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Compounding Pharmacies

Read The Full Cancer Supportive Care Products Market Report Here

https://www.thebusinessresearchcompany.com/report/cancer-supportive-care-products-global-market-report

The Cancer Supportive Care Products Global Market Report 2024 provides an overview of the cancer supportive care productsmarket for the time series: historic years (2010 – 2021) and ten years forecast (2023 – 2032). The cancer supportive care products market forecast analyzes cancer supportive care products market size, cancer supportive care products market share, leading competitor and their market positions.

The Table Of Content For The Cancer Supportive Care Products Market Include

1. Cancer Supportive Care Products Market Executive Summary
2. Cancer Supportive Care Products Market Segments
3. Cancer Supportive Care Products Market Size And Template Market Growth Rate
4.  Key Cancer Supportive Care Products Market Trends
5. Major Cancer Supportive Care Products Market Drivers
……
25. Key Mergers And Acquisitions In The Cancer Supportive Care Products Market
26. Top Cancer Supportive Care Products Companies
27. Cancer Supportive Care Products Market Opportunities And Strategies
28. Cancer Supportive Care Products Market, Conclusions And Recommendations
29. Appendix

Explore Similar Reports From The Business Research Company:

Cancer Biologics Market 2024

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Skin Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report

Pancreatic Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model